Neues Konzept leistet Vorschub für die Impfstoffentwicklung gegen Hepatitis C Lübeck – Ein vielversprechendes Konzept weckt die Hoffnung auf die Entwicklung eines wirksamen Impfstoffs gegen das Hepatitis-C-Virus (HCV). Neuartig konstruierte Immun...

A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons.  Emery H, Evans C, Jack K, Martello E, Seripenah P, Aiyelabegan F, Dhungana S, Joseph T, Koboto D, Morling JR, Stewart-Evans J, Wilson E...

Practical solutions to resolve social barriers to hepatitis C treatment initiation among people who inject drugs: a qualitative study.  Aung P, Hellard M, Dietze P, Petrovic B, Higgs P, Stoové M.  Harm Reduct J. 2024 Dec 20;21(1):221. ...

Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort.  Harney BL, Sacks-Davis R, van Santen DK, Stewart AC, Matthews GV, Carson JM, Klein MB, Lacombe K, Wittkop L, Salmon D, ...

Could chronic opioid use be an additional risk of hepatic damage in patients with previous liver diseases, and what is the role of microbiome?  Tarantino G, Cataldi M, Citro V.  Front Microbiol. 2024 Dec 2;15:1319897. doi: 10.3389/fmic...

Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities.  Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe...